Ovarian Low-grade Serous Carcinoma

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2026-04-17
Clinical Trial Update: A Study Combining the Peposertib (M3814) Pill With Standard Chemotherapy in Patients With Ovarian Cancer With an Expansion in High Grade Serous Ovarian Cancer and Low Grade Serous Ovarian Cancer [Phase 1]
Phase 1 study evaluating peposertib (M3814) in combination with standard chemotherapy for ovarian cancer, with expansions in high-grade sero…